Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031317 |
---|---|
Receipt number | R000035746 |
Scientific Title | Phase II study of TAS-102 plus bevacizumab as maintenance therapy after induction chemotherapy with bevacizumab, oxaliplatin, and fluoropyrimidine in patients with metastatic colorectal cancer |
Date of disclosure of the study information | 2018/02/16 |
Last modified on | 2018/02/15 15:43:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/02/15 15:44:57 |